Van ECK Associates Corp Sells 5,410 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Van ECK Associates Corp cut its holdings in Stericycle, Inc. (NASDAQ:SRCL) by 6.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 83,988 shares of the business services provider’s stock after selling 5,410 shares during the quarter. Van ECK Associates Corp’s holdings in Stericycle were worth $4,162,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of SRCL. Citigroup Inc. grew its holdings in shares of Stericycle by 0.6% during the third quarter. Citigroup Inc. now owns 46,953 shares of the business services provider’s stock worth $2,099,000 after buying an additional 285 shares in the last quarter. Strategic Blueprint LLC grew its stake in shares of Stericycle by 6.2% during the 4th quarter. Strategic Blueprint LLC now owns 5,609 shares of the business services provider’s stock worth $278,000 after acquiring an additional 326 shares in the last quarter. Raymond James Financial Services Advisors Inc. raised its holdings in shares of Stericycle by 4.9% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 7,243 shares of the business services provider’s stock valued at $359,000 after purchasing an additional 336 shares during the last quarter. Retirement Systems of Alabama lifted its position in shares of Stericycle by 0.3% in the fourth quarter. Retirement Systems of Alabama now owns 115,880 shares of the business services provider’s stock worth $5,743,000 after purchasing an additional 355 shares in the last quarter. Finally, Arizona State Retirement System boosted its holdings in Stericycle by 1.4% during the third quarter. Arizona State Retirement System now owns 26,322 shares of the business services provider’s stock worth $1,177,000 after purchasing an additional 358 shares during the last quarter. 98.82% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

SRCL has been the topic of several analyst reports. Robert W. Baird cut their price target on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a research report on Friday, April 26th. Royal Bank of Canada reiterated an “outperform” rating and set a $69.00 target price on shares of Stericycle in a report on Thursday, March 7th. StockNews.com cut Stericycle from a “buy” rating to a “hold” rating in a research report on Tuesday, April 2nd. Wells Fargo & Company upped their price objective on Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a research note on Friday, March 1st. Finally, Truist Financial cut their price objective on Stericycle from $57.00 to $50.00 and set a “hold” rating for the company in a report on Monday, April 29th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $59.40.

Stericycle Stock Performance

NASDAQ SRCL opened at $46.18 on Monday. The stock has a market cap of $4.29 billion, a PE ratio of -209.91, a P/E/G ratio of 2.49 and a beta of 1.12. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a 50-day moving average of $50.91 and a 200-day moving average of $48.28. Stericycle, Inc. has a 52-week low of $37.78 and a 52-week high of $57.06.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. The firm had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company’s revenue was down 2.8% on a year-over-year basis. During the same quarter last year, the company earned $0.49 EPS. On average, sell-side analysts anticipate that Stericycle, Inc. will post 2.32 EPS for the current year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.